Sensorion SA announced the appointment of Bernd Schmidt, a senior leader with extensive experience in Chemistry, Manufacturing and Controls (CMC), as Chief Technical Officer, effective as of December 12, 2023. Bernd Schmidt previously worked at Quell Therapeutics where he served as Vice President Product Delivery. He brings over 20 years of industry experience in the pharmaceutical sector, covering a broad range of innovative medicines at different stages in development and post launch.

Prior to his role at Quell Therapeutics, Bernd served as MPD Leader at GSK Stevenage with overall accountability for the CMC development, governance and end to end supply chain of a portfolio of medicines (small molecules and cell & gene therapies) covering preclinical to late-phase development as well as commercial supply, including interactions with regulatory bodies. Bernd holds a postgraduate degree in Chemical Engineering (MSc+) from the Friedrich-Alexander University of Erlangen, Germany, and is a Fellow of the Institution of Chemical Engineers.